Bph Global Limited · ASX:BP8
Bph Global — Investor Presentation (March 2021)
39 slides from Bph Global's investor presentation, Mar 9, 2021
Slide 1: Investor Presentation
Stemcell United Limited, ACN 009 104 330 Investor Presentation March 2021
Slide 2: Disclaimer
DISCLAIMER General • The information provided in this presentation pertaining to Stemcell United Limited, ACN 009 104 330 (“SCU" or the "Company"), its business assets, strategy and operations is for general informational purposes only and is not a formal offer to sell or a solicitation of an offer
Slide 3: Disclaimer: Forward Looking Statements and Financial Projections
DISCLAIMER Forward Looking Statements and Financial Projections • Certain information in this presentation and oral statements made in any meeting are forward-looking and relate to SCU and its anticipated financial position, business strategy, events and courses of action. Words or phrases such as "
Slide 4: At a Glance: SCU Overview
AT A GLANCE SCU Overview • By Stemcell United Limited (ASX:SCU). • Plant-based Biotechnology company focusing on Plant-Based Healthcare, Pharmaceutical Ingredients and Plant-Based Food Protein & Nutrients. • Established Presence in Asia Pacific Markets such as China and Australia. Strategic developm
Slide 5: At a Glance: SCU Overview
AT A GLANCE SCU Overview Plant-based Biotechnology Company Plant-Based Healthcare Plant-Based Food SCU Hemp Project SCU TCM Project SCU Sea Grape Project Skincare Topical Herbal Pharmaceutical Material: Medicinal Fresh Leafy Vegetables and (Nano-packaged CBx) dendrobium, Dragon blood, Psychedelic et
Slide 6: Key Investment Highlights
KEY INVESTMENT HIGHLIGHTS Cutting-Edge Biotechnology SCU plant stem cell technology application in seed bank development and cultivation as well as researching into nano-biotechnology to produce nano-packaged CBx and high-value nutraceutical active ingredients Seed Bank Development Partnering with C
Slide 7: Global Operations
GLOBAL OPERATIONS SCU Global strives to be the Leading Plant-Based Biotechnology Company to serve Asia Pacific region SCU Global Research and Sales and Headquarter Development Manufacturing Bases Marketing SCU Southeast Asia Huafang Singapore Plant Based SCU Australia Food and Nutrients (Malaysia) H
Slide 8: Our Founder
OUR FOUNDER PHILIP GU FOUNDER, CEO MSc, Plant Biology Started career as a 1990s Food Technologist in major Australian marine food companies Developed and Formulated 1991 World’s First Abalone Sauce Technology in Melbourne Australia Post-Harvest Development consultant for Food and 1990s Agriculture O
Slide 9: Key Appointments of the Board and Advisory
KEY APPOINTMENTS OF THE BOARD AND ADVISORY PAUL ROSEN ALAN DRONKERS DAVID PLATTNER GROUP CHAIRMAN STRATEGIC ADVISOR SUSTAINABILITY ADVISOR Rosen is an early pioneer in the globalized cannabis Alan Dronkers is currently Special Advisor to the David has over 50 years experience as an industry, having
Slide 10: SCU Hemp Project
SCU Hemp Project Sustainable Plant Based Health Solutions
Slide 11: Our Key Technologies
OUR KEY TECHNOLOGIES PATENTS AND LICENSES SCU has applied for international patent protection (PCT/SG2014/000515) for its proprietary technology and method of isolating meristematic plant stem cells. C H INA 1X 1X CBD SEED GENETIC CBD IMPORT- Patented HIGH CONCENTRATION EXPORT PERMIT OF CBD (HAAS) C
Slide 12: Key Business Highlights
KEY BUSINESS HIGHLIGHTS SCU Hemp Competitive Advantages Establishment of First Foreign Research on a range plant stem cell Company of Nano-grade CBD R&D centres for with fully-fledged Skincare hemp in China and licence in China Topical Applications Australia Entrance into Patented plant Research on
Slide 13: Key Business Development Segments
KEY BUSINESS DEVELOPMENT SEGMENTS HONGYI SCU SCU China: YUNNAN SCU SINGAPORE PTE SCU SOUTHEAST ASIA BIOTECHNOLOGY HUAFANG Subsidiary LTD SDN BHD INNOVATION CENTRE Biotechnology Application Areas CBX Application: Hemp Seed Bank CBX Distribution: R&D and Personal Care Development & Cosmetics Sales & M
Slide 14: Large Addressable Market
LARGE ADDRESSABLE MARKET HEMP VERSATILITY IN GLOBAL PERSONAL CARE PRODUCT MARKET Outside Body Nutricosmetics Cosmetics/ Personal Care Oral supplements that offer beautification Topical products that offer beautification and personal care/ hygiene Example: Hemp Oil Example: Hemp Toner 2018 2018 USD 5
Slide 15: Large Addressable Market
LARGE ADDRESSABLE MARKET CBx APPLICATION: PERSONAL CARE & COSMETICS Global Hemp Personal Care & Cosmetics Outlook (USD Million)1 China Personal Care & Cosmetics Outlook2 200 164 148 150 119 129 90 100 50 0 2016 2017 2018 2019 2020 China Personal Care & Cosmetics Market (RMB '00 Million) • Main facto
Slide 16: Large Addressable Market
LARGE ADDRESSABLE MARKET EVOLUTION OF KEY FACTORS IN THE SKINCARE INDUSTRY Factors 2015 2021 2025 Product development on pain points Balance between beauty and food Emergence of preventive like aging Multi-functional products for nutri-cosmetics products multiple target groups Inside-out approach “O
Slide 17: Key Strategic Partners
KEY STRATEGIC PARTNERS China Tobacco as our Key Cultivation & Innovation Partner • Key plantation partner with vast available land resources for hemp cultivation • Research collaboration: Establishing a Research Centre for Plant Stem Cell Bioengineering at Kunming • HSBIC (Innovation Centre) to show
Slide 18: Potential CBx Application & Personal Care
POTENTIAL CBx APPLICATION & PERSONAL CARE Market Description, Outlook and Growth Opportunities Business Partners’ Sector Product Description Market Trends Stage Demography Structure Resources Growth CBD Nano-packaged CBD Increasing demand Commercialisa Joint • licenced to China and Skincare in skinc
Slide 19: CBx Application & Personal Care
CBx APPLICATION & PERSONAL CARE Cannabidiol, CBD Green Caviar (Sea Grapes) CBD’s Properties 2: Sea Grape’s Properties: • Inhibit oil production Polysaccharides, APIs 1 on oil-producing glands • Moisturizing effects • Anti-inflammatory to give the damaged effects to reduce the skin with deep flare up
Slide 20: CBx Application & Nanopackaging
CBx APPLICATION & NANOPACKAGING (under development) Cannabinoids' Pain Points Advantages of Nanopackaging Economical • High lipo-philicity of CBD: Insoluble in water 1 • Low Cost of Application • Low safety profile: Presence of contaminants • Higher Product Value • Low stability: High degradation ra
Slide 21: Key Technologies and IP
KEY TECHNOLOGIES AND IP SCU Hemp acquires Competitive Technologies through Strategic Partnerships and Joint Ventures Partnership and TECH - Strategies Description IP Status Joint Ventures (JV) Academic and Joint • Partnerships with prominent research institutions University Patents registered: Resea
Slide 22: SCU TCM Project: Dendrobium & Dragon Blood
SCU TCM Project: Dendrobrium & Dragon Blood (Resina)
Slide 23: Our Technologies: Medicinal Orchid Dendrobium Officinale
OUR TECHNOLOGIES : Medicinal Orchid Specie Dendrobium Officinale DENDOBRIUM OFFICINALE FUNCTIONALITIES 1. Enhancement of immune functions: Increase Wild Dendrobium Officinale Kimura et Migo (铁皮石 immune cells & Improve immune systems1 斛) (“Dendrobium”) is a rare and endangered orchid 2. Anti-Cancer:
Slide 24: Our Technologies: Dendrobium Cultivation & Quality
OUR TECHNOLOGIES : DENDROBLIUM CULTIVATION & QUALITY SCU‘S DENDOBRIUM STEM CELL Extraction & Manipulation Dendobrium Stem Cells Growing Stem Cells in Filtration for of Stem Cells Bioreactor Extract Processing D U RAT ION: 2 – 3 M O NT H S VS. TRADITIONA LLY GROWN D U RAT ION: 3 – 6 Y EA RS S C U ’ S
Slide 25: Our Technologies: Dragon Blood Processing & Quality
OUR TECHNOLOGIES : DRAGON BLOOD PROCESSING & QUALITY DAEMONOROPS DRACO BLUME FUNCTIONALITIES 1 1. Treat body sprains and act as an analgesic Resina is extracted from Daemonorops Draco Blume, a plant that grows in the tropical rainforests of 2. Treat blood stasis and help in blood circulation Indones
Slide 26: SCU Sea Grape Project
+ SCU Sea Grape Project: 1. Natural Marine Plant-Based Proteins and Nutrients from Sea Grape and Other Seawee 2. Aim to achieve 1% of total Singapore local produced food nutrition (Singapor Agency 30X30)
Slide 27: Painpoint: Global Health is the Human Face of Climate Change
PAINPOINT: Global Health is the Human Face of Climate Change + Climate Change Food Security (Co₂) (Proteins) Logistics of Food Supply Increase in Carbon Gas Serious environmental risks and current global Global Carbon emissions have risen 11% since 2010 2 pandemics disrupt critical check point Tempe
Slide 28: About Us
ABOUT US The Sea Grape Project is developed to tackle Food Insecurity and mitigate Climate Change\. Key Business Highlights At A Glance 1 Core Business Capabilities Driver: Marine Plant-based Protein and Nutrients Fresh Products: Marine Leafy Vegetable; Downstream Products: Marine Plant–based Extrac
Slide 29: Solution: Sea Grape As Future Food
SOLUTION: Redefining Sea Food -- Sea Grape As Future Food Redefining Seafood Sea Grape is the new “Marine Plant-based Protein and Nutrient” What is Sea Grape Key Value Propositions as Future Food • Indigenous staple food with high commercial potential • Macro-algae Species • Good nutritional source:
Slide 30: The New Trend: Plant-Based Proteins
The New Trend: Plant-Based Proteins Plant-based Protein Market is Blooming Consumption of Animal Protein vs Plant-Based Protein 3 • Increasing awareness about the benefits of plant-based protein • The consumption of plant-based protein is estimated to have a and growing demand for protein-rich diet2
Slide 31: Sea Grapes Health Benefits & Fucoidan
SEA GRAPES HEALTH BENEFITS & FUCOIDAN Health Benefits Benefits of Fucoidan Helps Strengthen the Heart1 Contains unsaturated fatty acids AA, LA, DHA, EPA and ALA Protect against Neuro-Degeneration4 Fucoidan prevents the death of brain cells affected by Alzheimer’s disease and helps protect other heal
Slide 32: Partners in Key Technologies Across Value Chain
PARTNERS IN KEY TECHNOLOGIES ACROSS VALUE CHAIN Partner: Nanyang Technological Partner: Temasek Polytechnic University (NTU) Proprietary Cultivation Key Ingredient Sale and Formulation Marketing Short Harvest cycle and High harvest yield Seaweed/ Staple food/ Patty 1 3 5 2 4 6 Seed Bank Development
Slide 33: Seed Bank Singapore: Macro Algae
Seed Bank Singapore: Macro Algae The seed bank oversees propagation of new variety cultivars with selected and desired hereditary traits, that can be transplanted, and mass cultivated in diverse geographic regions. Repository of strains and species Acclimatization & Selection (library) • Different s
Slide 34: Ingredient Formulation
INGREDIENT FORMULATION Sea Grape Powder Sea Grape Marine Plant-Based Patty Dried powder of Caulerpa Lentillifera was produced Using Sea Grape dried powder, it will be integrated as one of from the ~5% of fresh biomass of sea grapes. the key ingredient in forming marine plant-based Sea Grape Patties
Slide 35: Singapore and Shenzhen as Launchpad to the World
SINGAPORE AND SHENZHEN AS LAUNCHPAD TO THE WORLD China Gulf Corporation Council (GCC) projects USD 53billion of Halal Food Import by 2020 Source: Africa Islamic Economic Foundation; The Global Halal Industry: An Overview
Slide 36: Ongoing Project Development
ONGOING PROJECT DEVELOPMENT Our Sea Grape Project currently operates in 2 countries: Singapore & China. SOUTH Sea Grape Project, St John Island, Singapore: • Seed Breeding • Urban Aquaculture Farming Solution Lantene Biotechnology ShenZhen, China: EAST & WEST • Seed Breeding Pasir Ris & Pandan Loop
Slide 37: Key Milestones & Investment Highlights
KEY MILESTONES & INVESTMENT HIGHLIGHTS Seed Bank Patents* Singapore Site 19 Sea Grape 15 2000m2 Commercial Sea Grape Production & Processing Seed Genetics Technologies Facilities Singapore Lab Secured Ongoing MAC MOA R&D Patents to be filed on R&D and Research Collaboration Genetic, Cultivation, & C
Slide 38: Corporate Info
Corporate Info Company Stemcell United Limited Company Status ASX Listed ACN 009 104 330 Country Australia Address: Level 12, 680 George Street Sydney NSW 2000 Australia URL www.scu.com.sg Source: Management
Slide 39: Unlocking the Limitless Potential of Plant Stem Cell Biotechnology
Unlocking the Limitless Potential of Plant Stem Cell Biotechnology T H A N K Y O U